NLS Pharmaceutics AG

NASDAQ:NLSP

4.15 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -12.172-16.496-11.946-2.861-5.447-5.147-6.657
Depreciation & Amortization 0.0110.0110.0172.188000
Deferred Income Tax 00.61300000
Stock Based Compensation 0.1650.02300000
Change In Working Capital 2.2521.627-3.1672.0644.1170.6680.34
Accounts Receivables 00-0.022-0.0130.001-0.0410
Inventory 0000-00.041-0
Accounts Payables 2.260.636-2.2691.4971.3790.5660.35
Other Working Capital -0.0090.991-0.8750.582.7370.102-0.01
Other Non Cash Items -2.0130.3650.167-72.121.1411.7460.884
Operating Cash Flow -9.684-13.879-14.936-0.729-0.19-2.733-5.432
Investing Activities:
Investments In Property Plant And Equipment -00-0.040000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow 0-3.514-0.040.226-0.21700
Financing Activities:
Debt Repayment -1.634-0.704-2.105-1.19-0.668-0.558-0.003
Common Stock Issued 018.10118.8940003.277
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.0020.0173.5491.6941.0751.1163.45
Financing Cash Flow 1.63417.39720.3380.5040.4070.5586.727
Other Information:
Effect Of Forex Changes On Cash 0-0-00-0-0.0010.006
Net Change In Cash -8.0513.5175.337-0.1270.214-2.1761.3
Cash At End Of Period 0.8988.9485.4310.0940.220.0072.183